
17 June 2026
Malvern International PLC
("Malvern" or the "Company")
Appointment of Chief Financial Officer (CFO)
Malvern International plc (AIM: MLVN), the global learning and skills development partner, is pleased to announce the appointment of Daniel Chaffer as an executive director and CFO Designate with effect from 22 June 2026.
Daniel will work closely with the outgoing CFO, Dan Fisher, over the next few months ensuring a smooth and efficient handover. He will assume the role of CFO during the transition period prior to the departure of Dan Fisher in September 2026.
Daniel Chaffer is an experienced CFO and strategic finance leader with over 25 years' experience across professional services, technology, music and the pharmaceutical industries. He is a Fellow of the Institute of Chartered Accountants in England and Wales. Most recently, Daniel served as CFO of Sentric Music Group, a technology-driven music publishing business with £66m revenue, where he led the business through significant organic growth and post-acquisition financial integration. Prior to this he served as CFO of Bioscript Group, a PE-backed medical communications consultancy, overseeing a period of rapid growth from £8m to £28m revenue over a 4-year period, and the successful sale of the business to private equity. Earlier in his career Daniel spent nearly eight years at the BBC as a Finance Business Partner supporting high-profile production and commissioning departments.
Richard Mace, Chief Executive Officer, commented:
"The Board is delighted to have secured someone with Daniel's depth of experience, and to have done so in good time to facilitate an orderly handover at an exciting and busy time for the Group as it looks to build student numbers across its university pathway contracts and summer junior programmes. I would also like to thank Daniel Fisher for his significant contribution to Malvern and for his support in ensuring a smooth transition."
Daniel Chaffer, aged 48, currently holds no other directorships, and holds no ordinary shares or options in the Company.
|
Current directorships |
Past directorships held within the last five years |
|
None |
Sentric Music Ltd Masstrax Music Ltd Sentric Music Group Ltd Black Rock Publishing Ltd IQ Music Ltd Sentric Music Publishing Ltd Cancer Communications Ltd Cancer Communications and Consultancy Ltd Meridian Healthcomms Ltd Meridian Healthcomms Holdings Ltd Portland Medical Communications Ltd Valid Insight Ltd Bioscript Midco 2 Ltd Bioscript Midco 1 Ltd Sapience Medical Education Ltd Fortis Digital Ltd Fortis Pharma Consulting Ltd Azimuth Pharma Ltd Bioscript Holdings Ltd Bioscript Ltd |
There is no other information that is required to be disclosed pursuant to Schedule 2 paragraph (g) or Rule 17 of the AIM Rules for Companies.
For further information, please contact:
|
Malvern International Plc Richard Mace - Chief Executive Officer |
Via Zeus |
|
|
|
|
Zeus - Nominated Adviser and Broker Mike Coe / James Bavister |
https://zeuscapital.co.uk/ 0203 829 5000 |
Notes to Editors:
Malvern International is a learning and language skills development partner, offering international students essential academic and English language skills, cultural experiences and the support they need to thrive in their academic studies, daily life and career development.
University Pathways provides on-and off-campus in-sessional and pre-sessional programmes to support international students in progressing to a wide range of universities and undergraduate courses. Malvern assists its university partners with international student recruitment and conversion, admissions, fee collection, and course delivery, including teaching, orientation, and student support.
English Language Teaching is provided to young learners through fully immersive residential English language centres and customised language programmes at high-quality locations.
For further investor information go to www.malverninternational.com.